Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 19/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20007330 | 0.91 | TRPV4 (0.52) | TRPV4KCNH2CYP3A4TRPM8S1PR3 | |
| SCHEMBL23614058 | 0.89 | TRPV4 (0.52) | TRPV4KCNH2CYP3A4TRPM8S1PR3 | |
| SCHEMBL20007587 | 0.88 | TRPV4 (0.57) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL20007246 | 0.86 | TRPV4 (0.65) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL20007569 | 0.83 | TRPV4 (0.52) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL20007702 | 0.83 | TRPV4 (0.54) | TRPV4KCNH2CYP3A4TRPM8S1PR3 | |
| SCHEMBL23614050 | 0.81 | TRPV4 (0.51) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL19995710 | 0.81 | TRPV4 (0.74) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL20007457 | 0.81 | TRPV4 (0.74) | TRPV4KCNH2CYP3A4TRPM8 | |
| SCHEMBL19995711 | 0.81 | TRPV4 (0.74) | TRPV4KCNH2CYP3A4TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515887-B1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE IP NO 2 LTD (GB) | 2021-07-07 | — | — | EP | disclosed |
| WO-2018055524-A1 | TRPV4 ANTAGONISTS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2018-03-29 | — | — | WO | disclosed |